Hugel

Hugel EBIT per Employee

EBIT per Employee of Hugel (145020.KQ) as of Oct 19, 2026.

EBIT per Employee

-KRW

Last updated:

EBIT per Employee of Hugel is 2026 - KRW. EBIT per Employee of Hugel was 2025 - KRW. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hugel Stock analysis

What does Hugel do? Hugel Inc is a biotechnology company based in Chuncheon, South Korea, operating in the Health Care sector. It manufactures and sells biopharmaceuticals, including botulinum toxins for treating benign essential blepharospasm and moderate to severe glabellar lines in 50, 100, and 200 unit types. The company also produces hyaluronic acid fillers for facial wrinkles under various product lines such as Chaeum Premium and Chaeum MID. Hugel Inc went public on December 24, 2015, and markets its products domestically and internationally. Its website is http://www.hugel.co.kr/ Hugel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hugel stock

On Eulerpool you can find the complete historical development of EBIT per Employee Hugel since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Hugel historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Hugel

All Key Metrics — Hugel